Takeda Gives Up Patent For Hunter Syndrome Treatment
Japanese pharmaceuticals company Takeda has given up its European patent for a Hunter syndrome treatment after an appeals panel suggested that the therapy was not inventive....To view the full article, register now.
Already a subscriber? Click here to view full article